Implications of Developmental 17‐OHPC Exposure on the Mesocorticolimbic Serotonergic and Dopaminergic Pathways and Adolescent Mood–Related Behavior in Rats

Abstract

ABSTRACTThe synthetic progestin, 17‐α‐hydroxyprogesterone caproate (17‐OHPC), is administered to pregnant individuals at risk for recurrent preterm birth during a critical period of fetal mesocorticolimbic serotonergic and dopaminergic pathway development. These pathways play an important role in regulating cognitive behaviors later in life. Despite this, there has been very little research regarding the potential long‐term effects of 17‐OHPC on the behavioral and neural development of exposed children. In rodents, developmental exposure to 17‐OHPC disrupts serotonergic and dopaminergic innervation of the medial prefrontal cortex and impairs decision‐making in complex cognitive tasks in adulthood. The present study tested the hypothesis that developmental exposure to 17‐OHPC similarly disrupts the development of serotonergic and dopaminergic pathways within limbic targets and subsequent mood‐related behaviors. Developmental 17‐OHPC exposure significantly increased the density of serotonin transporter–IR fibers in CA1, CA2/3, and the suprapyramidal blade of dentate gyrus in hippocampus and significantly reduced the density of TH‐IR fibers within the nucleus accumbens shell in males but had no effect in females during adolescence. Irregular microglia activational phenotype and number were also observed in the hippocampus of 17‐OHPC‐exposed males. Developmental 17‐OHPC reduced the latency to immobility in males in the forced swim test but did not affect sucrose consumption in a sucrose preference test. These findings suggest that 17‐OHPC exerts sex‐specific effects on the development of mesocorticolimbic pathways and mood‐related behavior in adolescence and highlight the need to investigate effects in adolescent children.